Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wipfler-Freissmuth

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Zeitschrift Fur Rheumatologie|December 6, 2008
[Recommendations of the European League Against Rheumatism (EULAR) for the treatment of "large-vessel vasculitides"]E Wipfler-Freissmuth, F Moosig, M Schirmer
Zeitschrift Fur Rheumatologie|February 19, 2009
[Current therapeutic options for giant cell arteritis]E Wipfler-Freissmuth, J Loock, F Moosig, et al.
Scandinavian Journal of Rheumatology|January 15, 2011
Similar performance of DAS-28, CDAI, and SDAI in rheumatoid arthritis patients with and without sonographic signs of active inflammation in routine clinical practiceC Dejaco, C Duftner, E Wipfler-Freissmuth, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Zeitschrift Fur Rheumatologie|December 6, 2008
[Recommendations of the European League Against Rheumatism (EULAR) for the treatment of "large-vessel vasculitides"]E Wipfler-Freissmuth, F Moosig, M Schirmer
Zeitschrift Fur Rheumatologie|February 19, 2009
[Current therapeutic options for giant cell arteritis]E Wipfler-Freissmuth, J Loock, F Moosig, et al.
Scandinavian Journal of Rheumatology|January 15, 2011
Similar performance of DAS-28, CDAI, and SDAI in rheumatoid arthritis patients with and without sonographic signs of active inflammation in routine clinical practiceC Dejaco, C Duftner, E Wipfler-Freissmuth, et al.
Pageof 1